Animal Study Shows Potential to Advance Human COVID-19 Vaccine – A Layman’s Viewpoint

The announcement of a room temperature stable mRNA vaccine candidate by COVID-19 vaccine researchers suggests this advance might, potentially, revolutionize the entire field of vaccine production. This development opens the way to overcome at least one crucial obstacle that has made vaccines inaccessible, particularly, to under-developed nations and in remote areas within even developed countries.Continue reading “Animal Study Shows Potential to Advance Human COVID-19 Vaccine – A Layman’s Viewpoint”

Reasons to Not Simply Await A Vaccine: “Tricky Nature of COVID-19”

Advances in Scientific Research and Implications for Economic Development Potentially new emerging strain(s) of COVID-19 virus coupled with mounting losses of millions of human lives (estimated 13+ million infected worldwide[1]) within the span of a short half year, underscore the urgency to rigorously re-explore, expand and quickly adopt dynamical and non-mechanistic methods of scientific research,Continue reading “Reasons to Not Simply Await A Vaccine: “Tricky Nature of COVID-19””

COVID-19 Anomaly: recovered patients retest positive for viral infection

The valued scientific method of Lyndon H. LaRouche, Jr. may well become the sole avenue through which a competent, much needed comprehension of how to halt COVID- 19’s deadly specter around the globe will happen.    More questionable, rather than definitive, findings continue to emerge regarding crucial facets of COVID-19 (SARS-Cov-2).  Disturbing and of greatContinue reading “COVID-19 Anomaly: recovered patients retest positive for viral infection”

COVID-19 Vaccine Development, an International Endeavor

[June 12, 2020] The quest to produce a viable, safe vaccine to halt the COVID-19 pandemic and be able to meet an aggressive schedule for the roll out of millions of doses by the close of 2020 has become a worldwide endeavor, with 10 announced potential candidates.  These vaccine developers are recruiting and enrolling participantsContinue reading “COVID-19 Vaccine Development, an International Endeavor”

Dodger Stadium Set up as Giant Testing Site in Los Angeles

May 26 (EIRNS)—The city of Los Angeles opened its largest coronavirus testing site Tuesday at Dodger Stadium, where up to 6,000 people can be tested daily free of charge. Mayor Eric Garcetti said in a news conference that “this builds on our work weve been doing [over the] past weeks and months. We want testingContinue reading “Dodger Stadium Set up as Giant Testing Site in Los Angeles”

Update: Massachusetts Contact Tracing and Expanded COVID-19 Testing May 26, 2020

Since this site’s last report on the Massachusetts COVID-19 Community Tracing Collaborative (CTC) 3 weeks ago, tracing teams have phoned approximately 30,000 of persons confirmed positive in the state, have reached close to 20,000 of them  and have interviewed as many as 10,000 of their close contacts. Caller ID phone exchanges 833 or 857 have been utilized toContinue reading “Update: Massachusetts Contact Tracing and Expanded COVID-19 Testing May 26, 2020”

Boris Johnson Convenes a Vaccine Summit June 4; Putin Is Invited

Summit to support the Global Alliance for Vaccines and Immunization — GAVI May 27, 2020 (EIRNS) — British Prime Minister Boris Johnson is convening a virtual Global Vaccine Summit 2020 on June 4th, and, according to the British Embassy in Moscow, has invited Russian President Vladimir Putin to take part in it. The summit aimsContinue reading “Boris Johnson Convenes a Vaccine Summit June 4; Putin Is Invited”

New Study of Novel Coronavirus Lineage Shows One Strain in Shanghai Different from That in the Wuhan Market

May 27 (EIRNS)—A new study soon to be published in Nature magazine, and referenced in today’s Global Times, shows that the type of coronavirus that appeared in some patients in Shanghai was unrelated to the type shown in the patients who were infected at the Huanan Seafood market in Wuhan. “Chinese scientists have discovered aContinue reading “New Study of Novel Coronavirus Lineage Shows One Strain in Shanghai Different from That in the Wuhan Market”

Uncertainties: ‘COVID-19 Convalescent Plasma’ Study

Early indicators have been released from a clinical study which collected, distributed and administered ‘COVID-19 convalescent plasma’ as investigational treatment to 8,932 patients confirmed COVID-19 positive. The study, which reports data from the first 5,000 of those study patients, was a joint trial run by the U.S. Food & Drug Administration (USFDA), the Mayo Clinic,Continue reading “Uncertainties: ‘COVID-19 Convalescent Plasma’ Study”